CS
GDRX icon

Credit Suisse’s GoodRx Holdings GDRX Stock Holding History

Credit Suisse’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-179,700
Closed -$7.37M – 4565
2021
Q3 		$7.37M Buy
179,700
+16,400
+10% +$595K ﹤0.01% 1744
2021
Q2 		$5.88M Hold
163,300
– – ﹤0.01% 1951
2021
Q1 		$6.37M Buy
+163,300
New +$7.34M ﹤0.01% 1880

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
RRCP
Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return

Credit Suisse's GDRX Position: Q1 2024 in Review

Credit Suisse reduced its GoodRx Holdings (GDRX) stake by 12% in Q1 2024, selling an estimated $73.1K and leaving 84,485 shares worth $600K. The position accounts for ﹤0.01% of the portfolio, ranked #2553.

Credit Suisse first reported a position in GDRX in Q4 2020 and has held it in 14 quarters since. The position peaked at $7.56M in Q2 2021. 159 funds tracked by Wall St. Rank hold GDRX as of Q1 2024.

  • Credit Suisse held 84,485 shares of GoodRx Holdings worth $600K as of Q1 2024.
  • Credit Suisse sold 11,048 GoodRx Holdings shares in Q1 2024, an estimated $73.1K.
  • GoodRx Holdings made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2553 holding.
  • Credit Suisse first reported a position in GoodRx Holdings in Q4 2020 and has held it in 14 quarters since.
  • Credit Suisse's GoodRx Holdings position peaked at $7.56M in Q2 2021.
  • 159 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.